Observational study of the immunogenicity of heptavalent pneumococcal conjugate vaccine in very-low-birth-weight infants.
Phase of Trial: Phase IV
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 20 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jul 2010 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 22 Jun 2008 Actual patient number (368) added as reported by ClinicalTrials.gov.